Activity of Antifilarial Drugs on Microfilaremia in the Treatment of Loiasis: A Systematic Review [PDF]
Background Loiasis, caused by the nematode/filaria Loa loa, presents a major health burden in Central and West Africa. Despite the growing recognition of loiasis’ medical significance, current antifilarial drugs remain inadequate in terms of efficacy and
Michael Ramharter +2 more
exaly +3 more sources
Factors Associated With the Periodicity of Loa Loa Microfilaremia in the Republic of the Congo
Background Loa loa microfilariae circulate in the peripheral blood of human hosts following a diurnal periodicity, with maximal microfilaremia levels generally observed between 10:00 am and 3:00 pm.
Michel Boussinesq +2 more
exaly +2 more sources
Persistent Microfilaremia Caused by Dirofilaria asiatica Infection in 2-Year-Old Child, Sri Lanka, 2024 [PDF]
Filarial nematodes cause significant illness worldwide, including lymphatic and subcutaneous filariases in tropical regions. Dirofilaria asiatica is a recently described canine filarioid increasingly implicated in zoonotic human infections.
Ushani Atapattu +9 more
doaj +2 more sources
Not a Dead-End Host: First Confirmed Persistent Microfilaremia in Human Dirofilaria repens Infection [PDF]
We report the first confirmed case of persistent microfilaremia in a human host infected with Dirofilaria repens. A 54-year-old woman from an endemic area in Croatia presented with peripheral eosinophilia and dermatological symptoms.
Martina Perešin Vranjković +7 more
doaj +2 more sources
Dirofilaria asiatica Infection and Asymptomatic Microfilaremia, Sri Lanka, 2025 [PDF]
We report 2 cases of asymptomatic Dirofilaria microfilaremia in humans in Sri Lanka, detected during night blood surveillance for lymphatic filariasis in 2025.
Dilini Mataraarachchi +11 more
doaj +2 more sources
Subcutaneous dirofilariosis in dogs, caused by Dirofilaria repens, is an underdiagnosed disease, now recognized for its zoonotic potential, and growing distribution and prevalence across Europe and Asia.
Marcin Wiśniewski +2 more
exaly +3 more sources
Efficacy and safety of albendazole 400 mg for 30 days compared to single dose of ivermectin in adult patients with low Loa loa microfilaremia: A non-inferiority randomized controlled trial. [PDF]
BackgroundLoa loa infection is endemic in central African countries and particularly in Gabon. Treatment typically involves the use of ivermectin and albendazole, with albendazole often administered to reduce microfilaremia in individuals with high ...
Luccheri Ndong Akomezoghe +8 more
doaj +2 more sources
Dirofilaria repens Microfilaremia in Humans: Case Description and Literature Review
Introduction: Dirofilaria repens is a vector-borne filaroid helminth of carnivorous animals, primarily domesticated dogs. Humans are considered to be accidental hosts in which D.
Jure Pupić-Bakrač +2 more
exaly +3 more sources
Chronic kidney disease related to Loa loa microfilaremia in a rural area of the Republic of Congo: a population-based cross-sectional study [PDF]
Background Loiasis affects millions in Central Africa and, though historically considered benign, emerging data suggest possible renal involvement. This study investigated the association between Loa microfilaremia and renal function.
Charlotte Boullé +12 more
doaj +2 more sources
Doxycycline and Eradication of Microfilaremia in Patients With Loiasis
Pierre-Édouard Fournier +2 more
exaly +3 more sources

